Publication List
Ɛсi2007Nj

Development of an antitumor adenosine analog, 3'-ethynyladenosine.
Endo Y, Obata T, Nomura M, Fukushima M, Yamada Y, Matsuda A, Sasaki T.
Nucleosides Nucleotides Nucleic Acids. 2007;26(6-7):691-4.

A novel apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis--the possibility of RNase L activated pathway as a target of ECyd.
Naito T, Yokogawa T, Kim HS, Matsuda A, Sasaki T, Fukushima M, Kitade Y, Wataya Y.
Nucleic Acids Symp Ser (Oxf). 2007;(51):435-6.

Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.
Endo Y, Obata T, Murata D, Ito M, Sakamoto K, Fukushima M, Yamasaki Y, Yamada Y, Natsume N, Sasaki T.
Cancer Sci. 2007 Oct;98(10):1633-7. Epub 2007 Aug 16.

Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
Kazuno H, Shimamoto Y, Tsujimoto H, Fukushima M, Matsuda A, Sasaki T.
Oncol Rep. 2007 Jun;17(6):1453-60.

Collagen gel matrix assay as an in vitro chemosensitivity test for malignant astrocytic tumors.
Ono A, Kanno H, Hayashi A, Nishimura S, Kyuma Y, Sato H, Ito S, Shimizu N, Chang CC, Gondo G, Yamamoto I, Sasaki T, Tanaka M.
Int J Clin Oncol. 2007 Apr;12(2):125-30. Epub 2007 Apr 27.

Antiangiogenic activity of TZT-1027 (soblidotin) on chick chorioallantoic membrane and human umbilical vein endothelial cells.
Watanabe J, Endo Y, Shimada N, Natsume T, Sasaki T, Kobayashi M.
In Vivo. 2007 Mar-Apr;21(2):297-304.

Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites.
Yonemura Y, Endo Y, Obata T, Sasaki T.
Cancer Sci. 2007 Jan;98(1):11-8. Review.

INDEX